Genicular Nerve Blocks and Peripheral Nerve Ablation for Knee Pain
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - North Carolina policy alerts
Know when Blue Cross Blue Shield - North Carolina releases new policies or updates existing guidance.
Monitor payer policy activity
Medicare-focused clinical policy describing coverage stance for genicular nerve blocks and peripheral nerve ablation (including RFA, cryoablation, cryoneurolysis) for treatment of knee osteoarthritis pain for Blue Cross NC Medicare products and supported third-party Medicare plans.
Newly created policy implemented addressing genicular nerve blocks and peripheral nerve ablation for knee pain.
Coverage Criteria
Not medically necessary / investigational
Not covered — investigational
BCBSNC does not provide coverage for investigational services or procedures; exception for facet joint pain for peripheral nerve ablation noted in source.
Blue Cross Blue Shield of North Carolina considers ablation of peripheral nerves to treat pain to be investigational for all applications and diagnoses, with the single exception of procedures performed for facet joint pain. These procedures have not been demonstrated to improve patient clinical outcomes, and therefore BCBSNC does not provide coverage for peripheral nerve ablation outside the facet joint pain indication.
Specifically, genicular nerve blocks (GNB), radiofrequency ablation (RFA), cryoablation, cryoneurolysis, and related minimally invasive ablation techniques for the treatment of knee pain are considered investigational and not medically necessary. These procedures — whether performed before or after knee replacement, or offered as alternatives to surgical management — will not be approved by the Plan for knee osteoarthritis or other knee pain diagnoses.
Coding and Diagnostic Details
| K1737637 | iovera system expanded indications (FDA 2017) for relief of pain and symptoms associated with osteoarthritis of the knee for up to 90 days |
| K163461 | Coolief Cooled RF Probe 510(k) clearance (2017) for creating RF lesions of the genicular nerves for management of moderate to severe knee pain |
Provider Actions and Prior Authorization
Applicable codes — prior authorization/medical necessity review
This policy lists specific CPT/CPT‑like procedure codes that may be associated with the services described; inclusion of these codes does not guarantee reimbursement and may be subject to medical necessity review.
Conservative nonsurgical management required before procedural intervention
Conservative nonsurgical management is described as the initial approach for knee osteoarthritis and should be attempted before considering procedural interventions.
- Examples include exercise, weight loss, supportive devices, acetaminophen/NSAIDs, nutritional supplements, and intra‑articular therapies (corticosteroid injections, viscosupplementation)
- Corticosteroid injections may be considered when NSAIDs are ineffective or contraindicated; if conservative measures fail, surgical options may be indicated
Medical records may be requested for medical necessity review
The Plan may request medical records to determine medical necessity; when records are requested, include the specific information needed to make a medical necessity determination because letters of support alone are often not sufficient.
- The Plan may request medical records for determination of medical necessity
- Letters of support/explanation are often useful but are not sufficient unless they contain all specific information needed for medical necessity determination
Investigational procedures — risk of claim denial
Genicular nerve blocks, radiofrequency ablation, cryoablation, cryoneurolysis, alcohol/anesthetic/steroid injections, and other peripheral nerve ablation procedures for knee pain are considered investigational and therefore will not be approved; performing these procedures risks denial.
- Minimally invasive ablation procedures for knee pain are considered experimental/investigational and BCBSNC does not provide coverage for investigational services or procedures
- Ablation of peripheral nerves to treat pain is investigational for all applications and diagnoses, except for facet joint pain
Background
Knee osteoarthritis is a common cause of chronic pain and functional impairment in older adults. Standard management emphasizes symptom relief and functional improvement through conservative nonsurgical measures such as exercise, weight loss, supportive devices, pharmacologic therapy (eg, acetaminophen, NSAIDs), and intra‑articular therapies (eg, corticosteroids, viscosupplementation). Although peripheral nerve ablation techniques including RFA and cryoneurolysis have been proposed as minimally invasive options to reduce pain, the Plan regards these approaches as investigational for knee pain because a clear demonstration of improved clinical outcomes is lacking.
Definitions
Conservative Treatment Requirements
Conservative treatment requirements
Documented failure of conservative nonsurgical management is described in the background but does not change the investigational policy stance.
Although conservative therapy is described in the background as preceding surgical options, the policy states that genicular nerve blocks and peripheral nerve ablation remain investigational and are not covered regardless of prior conservative treatment.
Frequency and Procedural Requirements
Imaging and Procedure Planning
Use fluoroscopic or ultrasound guidance for GNB/RFA planning
Diagnostic genicular nerve block and planning for radiofrequency ablation are usually performed under fluoroscopic or ultrasonographic guidance; fluoroscopy or ultrasound is recommended for procedure planning.
- Diagnostic genicular nerve block is usually performed under fluoroscopic or ultrasonographic guidance prior to planning RFA.
Not Covered
The following procedures and indications are explicitly not covered by the Plan when performed to treat knee pain: genicular nerve blocks (GNB) for the purpose of treating knee pain; radiofrequency ablation (RFA) of peripheral nerves for knee pain, including cooled and pulsed modalities; cryoablation / cryoneurolysis of peripheral nerves for knee pain; and chemical ablation techniques such as alcohol/anesthetic/steroid injections and other minimally invasive peripheral nerve ablation procedures. These services are considered investigational for all applications and diagnoses and will not be approved.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.